Research unit aims to find cure for neurodegenerative diseases  

2006.12.13
A new public-private sector research consortium comprising Aalborg University and USA's Wyeth Research, has been set up with the aim of finding cures for neurodegenerative diseases such as Parkinson's Disease
A new public-private sector research consortium comprising Aalborg University and Wyeth Research, a division of USA's Wyeth Pharmaceuticals, has been established with the aim of finding cures for neurodegenerative diseases such as Parkinson's Disease. The Cure Neurodegeneration Denmark (CureND) project has a budget of DKK 41.7 m (USD 7.5 m), of which DKK 12.5 m (USD 2.3 m) comes from public sector grants and DKK 29.2 m (USD 5.3 m) from Wyeth.
 
The research scientists hope to identify the proteins and biochemical processes that cause neurodegenerative diseases, and to find pharmaceutical compounds which can be used for the treatment of Parkinson's Disease. Professor Daniel Otzen of Aalborg University, who heads the project together with Dr. Peter Reinhardt of Wyeth, says: "The consortium will tie together a lot of threads in this area, and we can make a difference because we have many resources working on the case."
 
CureND research and company partners are the Department of Biotechnology, Chemistry and Environmental Engineering at Aalborg University, the Department of Health Science and Technology at Aalborg University, the Institute of Medical Biochemistry at the University of Aarhus, the Department of Molecular Biology at the University of Aarhus, the Parkinson's Disease Clinic at Aarhus University Hospital, Wyeth Research, Bioneer A/S and NemoMed A/S. The news was reported by financial daily newspaper Børsen.

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×